Skip to main content

Spearhead Capital Advisors, LLC

SEC CIK
0001718982
Latest filing
Nov 9, 2022

CSTL holding history

Castle Biosciences Inc in every 13F filed by Spearhead Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CSTL overviewAll 13F holders of CSTLFull Q3 2022 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2022
Holdings of CSTL by Spearhead Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−7,437−100.0%Sold outHolders
Q1 20227,437$334.0K<0.1%+7,437NewHolders